AUG 20, 2026 · PHASE 3 TRIAL
A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus
ClinicalTrials.gov
This is a Phase 3 trial registration with no results posted; the study is not yet recruiting, so no efficacy or safety data are available to evaluate.
Reported
Planned enrollment351
PhasePhase 3
Primary outcome 1Percent change from baseline to Week 52 in…